Kathrin Jansen to Adolescent
This is a "connection" page, showing publications Kathrin Jansen has written about Adolescent.
Connection Strength
0.072
-
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021 07 15; 385(3):239-250.
Score: 0.007
-
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021 07; 595(7868):572-577.
Score: 0.007
-
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 12 31; 383(27):2603-2615.
Score: 0.006
-
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. N Engl J Med. 2020 12 17; 383(25):2439-2450.
Score: 0.006
-
S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine. J Infect. 2019 12; 79(6):582-592.
Score: 0.006
-
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 2019 09 30; 37(42):6201-6207.
Score: 0.006
-
Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents. Vaccine. 2019 03 14; 37(12):1710-1719.
Score: 0.006
-
A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec. mSphere. 2018 12 05; 3(6).
Score: 0.005
-
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine. Expert Rev Vaccines. 2018 06; 17(6):461-477.
Score: 0.005
-
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults. N Engl J Med. 2017 12 14; 377(24):2349-2362.
Score: 0.005
-
Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France. Vaccine. 2017 03 13; 35(11):1530-1537.
Score: 0.005
-
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies. Vaccine. 2017 02 22; 35(8):1132-1139.
Score: 0.005
-
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatr Infect Dis J. 2013 Apr; 32(4):364-71.
Score: 0.004